Sinovac Biotech
40°01′52″N 116°18′01″E / 40.031°N 116.3003°E
 | |||||||
 | |||||||
| Company type | Public | ||||||
|---|---|---|---|---|---|---|---|
| NASDAQ: SVA | |||||||
| Founded | 1999 | ||||||
| Founder | Yin Weidong[1] | ||||||
| Headquarters | 39 Shang Di West Road, Haidian District, , China | ||||||
Number of employees | 4,281 (as of 2022)[2] | ||||||
| Chinese name | |||||||
| Simplified Chinese | 科兴控股生物技术有限公司 | ||||||
| Traditional Chinese | 科興控股生物技術有限公司 | ||||||
| Literal meaning | Kexing Holdings Biotechnology Co., Ltd. | ||||||
| |||||||
| Website | www | ||||||
Sinovac Biotech Ltd. (Chinese: 科兴控股生物技术有限公司, NASDAQ: SVA) is a Chinese biopharmaceutical company. They focus on the research, creation and selling of vaccines that protect against human infectious diseases. The company is based in Haidian District, Beijing in China.[3]
References
[change | change source]- ↑ "China's Vaccine Front-Runner Aims to Beat Covid the Old-Fashioned Way". Bloomberg. 24 August 2020.
- ↑ Submission Proof - tv479639
- ↑ "Home (English)". Sinovac. Retrieved 2021-03-06.
Add: No. 39 Shangdi Xi Road, Haidian District, Beijing, P.R.C. 100085
- Chinese address: "地址：北京市海淀区上地西路39号北大生物城"
